直肠胃肠道间质瘤切除术后肺转移。

Q4 Medicine
Seiko Harada, Shinzo Takamori, Daigo Murakami, Yusuke Uchida, Masaki Kashihara, Fumihiko Fujita, Takefumi Yoshida, Kenichi Koushi, Toshihiro Hashiguchi, Masahiro Mitsuoka, Yoshito Akagi
{"title":"直肠胃肠道间质瘤切除术后肺转移。","authors":"Seiko Harada, Shinzo Takamori, Daigo Murakami, Yusuke Uchida, Masaki Kashihara, Fumihiko Fujita, Takefumi Yoshida, Kenichi Koushi, Toshihiro Hashiguchi, Masahiro Mitsuoka, Yoshito Akagi","doi":"10.2739/kurumemedj.MS7134003","DOIUrl":null,"url":null,"abstract":"<p><p>A 71-year-old woman who had received resection for gastrointestinal stromal tumor (GIST) in the rectum after imatinib mesylate administration, revealed a pulmonary nodule measuring 11 × 10 mm in the right lung on chest computed tomography (CT), which was 26 months after the operation. The pulmonary nodule had gradually increased to 13 × 13 mm in diameter on follow-up chest CT. The standardized uptake value (SUV) of the pulmonary nodule on positron emission tomogram (PET) with 2-fluoro-2-deoxy-D-glucose (FDG) was 1.8. For diagnostic and therapeutic purposes, thoracoscopic partial resection of the lung, including the nodule, was performed. The pathological findings showed pulmonary metastasis from rectal GIST. On immunohistochemical examination, the tumor was diagnosed as the high-risk group, whereas the primary site in the rectum was the lowrisk group according to the Modified Fletcher classification. Imatinib mesylate was administered again, but her disease progressed. Although pulmonary metastasis from rectal GIST is a rare disease with a possible poor prognosis, pathological diagnosis should be essential to deciding treatment modality.</p>","PeriodicalId":39559,"journal":{"name":"Kurume Medical Journal","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2025-06-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Pulmonary Metastasis after Resection for Gastrointestinal Stromal Tumor in the Rectum.\",\"authors\":\"Seiko Harada, Shinzo Takamori, Daigo Murakami, Yusuke Uchida, Masaki Kashihara, Fumihiko Fujita, Takefumi Yoshida, Kenichi Koushi, Toshihiro Hashiguchi, Masahiro Mitsuoka, Yoshito Akagi\",\"doi\":\"10.2739/kurumemedj.MS7134003\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>A 71-year-old woman who had received resection for gastrointestinal stromal tumor (GIST) in the rectum after imatinib mesylate administration, revealed a pulmonary nodule measuring 11 × 10 mm in the right lung on chest computed tomography (CT), which was 26 months after the operation. The pulmonary nodule had gradually increased to 13 × 13 mm in diameter on follow-up chest CT. The standardized uptake value (SUV) of the pulmonary nodule on positron emission tomogram (PET) with 2-fluoro-2-deoxy-D-glucose (FDG) was 1.8. For diagnostic and therapeutic purposes, thoracoscopic partial resection of the lung, including the nodule, was performed. The pathological findings showed pulmonary metastasis from rectal GIST. On immunohistochemical examination, the tumor was diagnosed as the high-risk group, whereas the primary site in the rectum was the lowrisk group according to the Modified Fletcher classification. Imatinib mesylate was administered again, but her disease progressed. Although pulmonary metastasis from rectal GIST is a rare disease with a possible poor prognosis, pathological diagnosis should be essential to deciding treatment modality.</p>\",\"PeriodicalId\":39559,\"journal\":{\"name\":\"Kurume Medical Journal\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2025-06-13\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Kurume Medical Journal\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.2739/kurumemedj.MS7134003\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Kurume Medical Journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2739/kurumemedj.MS7134003","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

摘要

一位71岁的女性患者在接受甲甲酸伊马替尼治疗后行直肠胃肠道间质瘤(GIST)切除术,术后26个月胸部计算机断层扫描(CT)显示右肺一肺结节,大小为11 × 10 mm。随访胸部CT显示肺结节直径逐渐增大至13 × 13 mm。2-氟-2-脱氧-d -葡萄糖(FDG)正电子发射断层扫描(PET)肺结节的标准化摄取值(SUV)为1.8。为了诊断和治疗的目的,胸腔镜部分切除肺,包括结节。病理表现为直肠间质瘤肺转移。经免疫组化检查,肿瘤为高危组,原发部位为直肠,按照Modified Fletcher分类为低危组。再次给予甲磺酸伊马替尼,但病情进展。虽然直肠间质瘤的肺转移是一种罕见的疾病,预后可能较差,但病理诊断应是决定治疗方式的必要条件。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Pulmonary Metastasis after Resection for Gastrointestinal Stromal Tumor in the Rectum.

A 71-year-old woman who had received resection for gastrointestinal stromal tumor (GIST) in the rectum after imatinib mesylate administration, revealed a pulmonary nodule measuring 11 × 10 mm in the right lung on chest computed tomography (CT), which was 26 months after the operation. The pulmonary nodule had gradually increased to 13 × 13 mm in diameter on follow-up chest CT. The standardized uptake value (SUV) of the pulmonary nodule on positron emission tomogram (PET) with 2-fluoro-2-deoxy-D-glucose (FDG) was 1.8. For diagnostic and therapeutic purposes, thoracoscopic partial resection of the lung, including the nodule, was performed. The pathological findings showed pulmonary metastasis from rectal GIST. On immunohistochemical examination, the tumor was diagnosed as the high-risk group, whereas the primary site in the rectum was the lowrisk group according to the Modified Fletcher classification. Imatinib mesylate was administered again, but her disease progressed. Although pulmonary metastasis from rectal GIST is a rare disease with a possible poor prognosis, pathological diagnosis should be essential to deciding treatment modality.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Kurume Medical Journal
Kurume Medical Journal Medicine-Medicine (all)
CiteScore
0.20
自引率
0.00%
发文量
33
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信